Date lodged: 6 July 2017
To ask the Scottish Government, in the light of the recommendation in the review by Dr Brian Montgomery that managed access schemes should be developed as an additional option rather than a replacement for patient access schemes, what the principles are for development of new processes; what types of schemes are being considered and what level of flexibility is being built-in to improve access and affordability of innovative new medicines.
Answered by: Shona Robison 2 August 2017
I refer the member to the answer to question S5W-10189 on 2 August 2017. All answers to written parliamentary questions are available on the Parliament’s website, the search facility for which can be found at: http://www.parliament.scot/parliamentarybusiness/28877.aspx